Publication:
Can ebselen prevent cisplatin-induced ovarian damage?

Simple item page
dc.contributor.authorSoyman, Zeynep
dc.contributor.authorUzun, Hafize
dc.contributor.authorBayindir, Nihan
dc.contributor.authorEŞREFOĞLU, MUKADDES
dc.contributor.authorBoran, Birtan
dc.contributor.institutionauthorBAYINDIR, NİHAN
dc.contributor.institutionauthorEŞREFOĞLU, MUKADDES
dc.date.accessioned2020-01-23T20:59:10Z
dc.date.available2020-01-23T20:59:10Z
dc.date.issued2018-06-01T00:00:00Z
dc.description.abstractPurpose The occurrence of ovarian damage is a major shortcoming in treating tumors with cisplatin (CP). The present study investigates the beneficial effects of ebselen-a seleno-organic compound with antioxidant and antiinflammatory properties-vis-a-vis CP-induced ovarian damage.
dc.identifier.citationSoyman Z., Uzun H., Bayindir N., EŞREFOĞLU M., Boran B., -Can ebselen prevent cisplatin-induced ovarian damage?-, ARCHIVES OF GYNECOLOGY AND OBSTETRICS, cilt.297, ss.1549-1555, 2018
dc.identifier.doi10.1007/s00404-018-4750-4
dc.identifier.pubmed29600321
dc.identifier.scopus85044516528
dc.identifier.urihttps://openaccess.bezmialem.edu.tr/handle/20.500.12645/13481
dc.identifier.wosWOS:000431871800023
dc.language.isoen
dc.titleCan ebselen prevent cisplatin-induced ovarian damage?
dc.typeArticle
dspace.entity.typePublication
local.avesis.id210a9d15-b2ef-4e22-bbc9-2d421162f347
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1
relation.isAuthorOfPublication3c2743d0-b951-4eb5-bdd8-1c932e717700
relation.isAuthorOfPublicationd0c7c343-3b7d-47ef-a2a7-5169234110eb
relation.isAuthorOfPublication.latestForDiscovery3c2743d0-b951-4eb5-bdd8-1c932e717700

Files

Collections

Yayınlar - Eserler